Goldman Sachs’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $58.1M | Buy |
|
|||||
|
2025
Q2 | $13.9M | Sell |
|
|||||
|
2025
Q1 | $13.1M | Sell |
|
|||||
|
2024
Q4 | $14.4M | Buy |
|
|||||
|
2024
Q3 | $13.3M | Buy |
|
|||||
|
2024
Q2 | $8.42M | Sell |
|
|||||
|
2024
Q1 | $18.3M | Sell |
|
|||||
|
2023
Q4 | $80.6M | Sell |
|
|||||
|
2023
Q3 | $114M | Buy |
|
|||||
|
2023
Q2 | $112M | Buy |
|
|||||
|
2023
Q1 | $83M | Buy |
|
|||||
|
2022
Q4 | $48.3M | Sell |
|
|||||
|
2022
Q3 | $55.3M | Buy |
|
|||||
|
2022
Q2 | $41.5M | Sell |
|
|||||
|
2022
Q1 | $54.1M | Buy |
|
|||||
|
2021
Q4 | $52M | Buy |
|
|||||
|
2021
Q3 | $32.4M | Sell |
|
|||||
|
2021
Q2 | $39.5M | Buy |
|
|||||
|
2021
Q1 | $17.1M | Sell |
|
|||||
|
2020
Q4 | $26.4M | Buy |
|
|||||
|
2020
Q3 | $7.4M | Buy |
|
|||||
|
2020
Q2 | $1.48M | Buy |
|